Final Guidance Focuses on Radiolabeled Mass Balance Studies of Investigational Drugs

The FDA has issued a final guidance with recommendations on clinical pharmacology considerations for conducting human radiolabeled mass balance studies, including deciding whether and when to conduct the study, designing the study, and reporting results.
Source: Drug Industry Daily